Mar 2, 2014 — Last July, when the FDA approved unrestricted sale of Plan B One-Step, it also granted the drug's maker three years of protection from generic competition. Now the agency has reconsidered.
Feb 27, 2014 — The FDA has released its mock-up of a proposed new label for food. On it, calorie counts go big and bold. What's out? Listing calories from fat. What else is new? More details on added sugars.
Feb 26, 2014 — Researchers say they can replace DNA in human eggs with genetic material from another woman to prevent devastating disorders in children. But big questions remain on safety and ethics.
Feb 26, 2014 — As they wait for the Food and Drug Administration to propose regulations for the nascent e-cigarette industry, lobbyists frame the product as way to move tobacco smokers "down ladder of risk."
Feb 21, 2014 — The Food and Drug Administration says the long list of side effects read rapidly at the end of pharmaceutical ads may be too much for people to grasp. The agency is looking at a streamlined approach.
Jan 16, 2014 — Acetaminophen overdoses, many of which are inadvertent, are a leading cause of acute liver failure. People taking several kinds of drugs may not realize that more than one of them can contain acetaminophen.
Dec 6, 2013 — While the company tries to work things out with regulators, it won't be telling people who buy its test if their genetic profiles predispose them to particular illnesses or predict their responses to prescription drugs.
Nov 14, 2013 — The hospital says it can't guarantee the supplements' safety because of lax regulations. The Food and Drug Administration does not routinely review the manufacturing of dietary supplements, which calls their safety and effectiveness into question, doctors say.
Nov 11, 2013 — Shire's purchase of ViroPharma is all about a medicine to prevent life-threatening swelling attacks caused by a genetic mutation. The drug, called Cinryze, costs more than $4,600 for each treatment. The annual bill can run hundreds of thousands of dollars for each patient.
Oct 24, 2013 — The painkiller OxyContin is already classified as a Schedule II drug because of the "severe" risk of addiction. Now the Food and Drug Administration wants to move Vicodin and other painkillers containing hydrocodone to Schedule II as well, citing soaring rates of addiction and overdose deaths.